Skip to content

Clinical trials

Tuberous Sclerosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tuberous Sclerosis Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20094
20121
20131
20161
20171
20211
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Cardiff University2
Jazz Pharmaceuticals2
Marinus Pharmaceuticals2
GRIN Therapeutics, Inc.1
Neurim Pharmaceuticals Ltd.1
Noema Pharma AG1
UK Kidney Association1
University Hospitals Bristol and Weston NHS Foundation Trust1
University of Nottingham1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tuberous Sclerosis15
Seizures5
Lymphangioleiomyomatosis3
Astrocytoma2
Angelman Syndrome1
Angiomyolipoma1
Atypical Hemolytic Uremic Syndrome1
Autism Spectrum Disorder1
Bartter Syndrome1
Calciphylaxis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.